Nasopharyngeal carcinoma with bone marrow metastasis: positive response to weekly paclitaxel chemotherapy
Sae Miyaushiro, Akira Kitanaka, Yoko Kubuki, Tomonori Hidaka, Kotaro Shide, Takuro Kameda, Masaaki Sekine, Ayako Kamiunten, Yoshiko Umekita, Takayuki Kawabata, Yoriko Ishiguro, Kazuya Shimoda, Sae Miyaushiro, Akira Kitanaka, Yoko Kubuki, Tomonori Hidaka, Kotaro Shide, Takuro Kameda, Masaaki Sekine, Ayako Kamiunten, Yoshiko Umekita, Takayuki Kawabata, Yoriko Ishiguro, Kazuya Shimoda
Abstract
A 51-year-old man with nasopharyngeal carcinoma underwent chemoradiotherapy with cisplatin and 5-fluorouracil, followed by a left cervical lymphadenectomy. Distant metastatic disease was excluded using fluoro-deoxyglucose positron emission tomography. Seven months later, bone marrow metastasis and disseminated intravascular coagulation were diagnosed. The patient received weekly paclitaxel therapy and maintained a good performance status for seven months. During the treatment period, the patient developed no severe organ toxicity except for neutropenia. Weekly paclitaxel may therefore be considered as the treatment of choice in patients with advanced or recurrent nasopharyngeal carcinoma with bone marrow metastasis.
Source: PubMed